Slc25a30 | solute carrier family 25, member 30
Physiological systems
18 / 24 physiological systems tested
5 Significantly impacted by the knock-out
Homeostasis/metabolism Adipose tissue Growth/size/body region Vision/eye Skeleton
13 No significant impact
6 Not tested
Data collections
Gene metrics:5Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
decreased total body fat amount | 2 supporting datasets | Slc25a30tm1a(EUCOMM)Wtsi | homozygote | Early adult | 6.51x10-7 | ||
abnormal vertebral arch morphology | 1 supporting dataset | Slc25a30tm1a(EUCOMM)Wtsi | homozygote | Early adult | 1.62x10-5 | ||
persistence of hyaloid vascular system | 1 supporting dataset | Slc25a30tm1a(EUCOMM)Wtsi | homozygote | Early adult | 6.98x10-6 | ||
increased lean body mass | 2 supporting datasets | Slc25a30tm1a(EUCOMM)Wtsi | homozygote | Early adult | 1.94x10-7 | ||
decreased circulating serum albumin level | 1 supporting dataset | Slc25a30tm1a(EUCOMM)Wtsi | homozygote | Early adult | 3.83x10-5 |
| | | | | | | | | |
External links
No external links available for Slc25a30.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Slc25a30tm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector es cell mouse |
Slc25a30tm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | es cell |